Ó£»¨ÊÓÆµ

Skip to main content

TableÌý3 Group comparisons between different smoking status

From: Smoking cessation improves health status of patients with chronic diseases: evidence from a longitudinal study of older adults in China

Variables

Total

Pre (Ref)

Post

Current

Never

P value (overall)

Self-rate

N = 10,825

N = 509

N = 913

N = 3597

N = 5806

&±ô³Ù; 0.001

3.25 (0.74)

3.08 (0.73)

3.27 (1.03)

3.23 (0.72)

3.28 (0.70)

Ìý

EQ-5D-3L

N = 10,331

N = 440

N = 987

N = 3361

N = 5543

&±ô³Ù; 0.001

0.62 (0.21)

0.74 (0.19)

0.58 (0.25)

0.64 (0.22)

0.61 (0.20)

Ìý

Blood analyses

 Wµþ°ä

N = 7796

N = 85

N = 158

N = 2814

N = 4739

&±ô³Ù; 0.001

6.16 (1.75)

6.32 (2.12)

6.17 (1.82)

6.34 (1.82)

6.05 (1.69)

Ìý

‽ö±ð³¾´Ç²µ±ô´Ç²ú¾±²Ô

N = 7795

N = 85

N = 158

N = 2814

N = 4738

&±ô³Ù; 0.001

14.0 (1.96)

15.0 (2.16)

14.3 (1.53)

14.8 (1.99)

13.5 (1.78)

Ìý

‽ö±ð³¾²¹³Ù´Ç³¦°ù¾±³Ù

N = 7902

N = 86

N = 158

N = 2849

N = 4809

&±ô³Ù; 0.001

41.2 (5.40)

43.5 (5.86)

43.1 (4.78)

43.0 (5.38)

40.0 (5.07)

Ìý

 M°ä³Õ

N = 7795

N = 85

N = 158

N = 2813

N = 4739

&±ô³Ù; 0.001

90.8 (7.74)

92.0 (7.29)

91.7 (7.10)

92.2 (8.03)

89.9 (7.45)

Ìý

 P±ô²¹³Ù±ð±ô±ð³Ù

N = 7793

N = 85

N = 158

N = 2812

N = 4738

&±ô³Ù; 0.001

208 (69.5)

206 (67.9)

213 (90.4)

202 (69.1)

212 (68.7)

Ìý

 B±«±·

N = 7881

N = 84

N = 160

N = 2835

N = 4802

&±ô³Ù; 0.001

15.8 (4.55)

17.2 (5.74)

16.8 (5.64)

16.4 (4.49)

15.5 (4.48)

Ìý

 C°ù±ð²¹³Ù¾±²Ô¾±²Ô±ð

N = 7873

N = 84

N = 160

N = 2832

N = 4797

&±ô³Ù; 0.001

0.80 (0.31)

0.89 (0.33)

0.99 (0.85)

0.88 (0.30)

0.75 (0.26)

Ìý

 Total cholesterol

N = 7880

N = 84

N = 160

N = 2835

N = 4801

&±ô³Ù; 0.001

191 (36.7)

190 (36.5)

177 (32.4)

185 (36.5)

195 (36.5)

Ìý

 T°ù¾±²µ±ô²â³¦±ð°ù¾±»å±ð²õ

N = 7880

N = 84

N = 160

N = 2835

N = 4801

0.005

143 (97.7)

153 (181)

147 (84.9)

138 (107)

146 (89.9)

Ìý

 HDL cholesterol

N = 7882

N = 84

N = 160

N = 2837

N = 4801

0.004

50.9 (13.2)

49.9 (18.2)

48.2 (11.0)

50.5 (14.3)

51.3 (12.5)

Ìý

 LDL cholesterol

N = 7881

N = 84

N = 160

N = 2835

N = 4802

&±ô³Ù; 0.001

111 (31.7)

112 (35.0)

97.5 (24.6)

107 (31.1)

114 (31.8)

Ìý

 C¸é±Ê

N = 7883

N = 84

N = 160

N = 2836

N = 4803

0.003

3.14 (6.98)

3.69 (8.92)

3.28 (6.96)

3.51 (7.90)

2.91 (6.33)

Ìý

 G±ô³Ü³¦´Ç²õ±ð

N = 7875

N = 84

N = 160

N = 2834

N = 4797

0.021

110 (38.1)

111 (34.3)

101 (19.3)

110 (38.1)

110 (38.7)

Ìý

‽ö²ú´¡1³¦

N = 7885

N = 86

N = 160

N = 2835

N = 4804

&±ô³Ù; 0.001

5.66 (0.99)

5.25 (0.77)

5.92 (0.68)

5.61 (0.96)

5.69 (1.02)

Ìý

 Uric acid

N = 7887

N = 84

N = 160

N = 2838

N = 4805

&±ô³Ù; 0.001

4.70 (1.29)

4.98 (1.40)

5.72 (1.47)

5.07 (1.33)

4.44 (1.19)

Ìý

 Cystatin C

N = 7771

N = 74

N = 54

N = 2838

N = 4805

&±ô³Ù; 0.001

4.69 (1.29)

5.82 (1.49)

5.79 (1.49)

5.07 (1.33)

4.44 (1.19)

Ìý

Physical measures

 Walk time

N = 5628

N = 39

N = 152

N = 2117

N = 3320

&±ô³Ù; 0.001

4.35 (2.34)

4.34 (1.67)

3.47 (2.27)

4.31 (2.42)

4.42 (2.29)

Ìý

 Systolic pressure

N = 9068

N = 92

N = 232

N = 3335

N = 5409

0.218

132 (20.0)

130 (18.0)

131 (17.1)

133 (20.2)

132 (20.0)

Ìý

 Diastolic pressure

N = 9068

N = 92

N = 232

N = 3335

N = 5409

&±ô³Ù; 0.001

76.6 (11.4)

77.8 (11.1)

79.4 (11.4)

77.3 (11.6)

76.1 (11.2)

Ìý

 P³Ü±ô²õ±ð

N = 9067

N = 92

N = 232

N = 3334

N = 5409

0.110

73.8 (9.68)

74.1 (12.5)

73.9 (12.9)

74.1 (9.98)

73.6 (9.27)

Ìý

 Grip strength

N = 8995

N = 90

N = 231

N = 3309

N = 5365

&±ô³Ù; 0.001

29.1 (9.84)

37.6 (9.95)

36.0 (10.2)

33.8 (10.1)

25.7 (8.07)

Ìý

 B²Ñ±õ

N = 8976

N = 91

N = 234

N = 3302

N = 5349

&±ô³Ù; 0.001

24.3 (14.9)

23.4 (3.70)

23.7 (3.81)

23.5 (7.14)

24.9 (18.5)

Ìý

 Lung function

N = 8947

N = 88

N = 230

N = 3292

N = 5337

&±ô³Ù; 0.001

282 (114)

344 (140)

333 (135)

311 (129)

260 (96.4)

Ìý

 B²¹±ô²¹²Ô³¦±ð

N = 8642

N = 89

N = 223

N = 3165

N = 5165

&±ô³Ù; 0.001

3.74 (0.39)

3.79 (0.40)

3.83 (0.38)

3.79 (0.36)

3.71 (0.40)

Ìý

 Chair 5 s

N = 8648

N = 86

N = 225

N = 3170

N = 5167

&±ô³Ù; 0.001

11.0 (4.20)

10.1 (3.01)

9.62 (3.24)

10.8 (4.14)

11.2 (4.26)

Ìý

 Chair 5 num

N = 8667

N = 86

N = 225

N = 3180

N = 5176

0.056

4.99 (0.15)

5.00 (0.00)

5.00 (0.00)

4.99 (0.19)

4.99 (0.11)

Ìý
  1. All significate outcomes compared with pre-cessation group (P < 0.05) were bold in the table
  2. Each project group's participant count, mean, and standard deviation of the indicators are described, with units indicated in Table S-1
  3. Current Current smokers, Pre Before cessation, Post After cessation, Never Non-smokers
  4. Abbreviation: EQ-5D-3L EuroQoL 5-Dimension 3-Level, WBC white blood cell count, MCV platelet count, mean corpuscular volume, BUN blood urea nitrogen, HDL high-density lipoprotein, LDL low-density lipoprotein, CRP C-reactive protein, HbA1c glycosylated hemoglobin, type A1c, BMI body mass index